SKI Market

A+| A| A-|

Indian Indices

Sensex

77,470.11 -238.41
( -0.31%)

Global Indices

Nasdaq

51,860.73 -306.69
(-0.59%)

Dow Jones

7,464.20 -14.49
(-0.19%)

Hang Seng

66,064.76 1,923.64
(3.00%)

Nikkei 225

10,542.79 -57.58
(-0.54%)

Forex

USD-INR

96.42 0.06
(0.07%)

EUR-INR

110.27 -0.10
(-0.09%)

GBP-INR

129.65 -0.46
(-0.35%)

JPY-INR

0.59 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Board of Directors

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532989

INE878I01022

40.6429546

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BAFNAPH

48.83

541.73

EPS(TTM)

Face Value()

Div & Yield %

4.69

E D & Wholetime Director	Shanmugam Hemalatha
ED / WTD	Vinayak Dinesh Dendukuri
Non-Exec & Non-Independent Dir	Upendar Mekala Reddy
Chairman & Independent Directo	Ravichandran Chitra
Company Sec. & Compli. Officer	A Mohanachandran
Non Executive Director	Akilapriya Chandrashekar Raju
Independent Non Exe. Director	Palamadai Krishnan Sundaresan

77,470.11 -238.41 ( -0.31%)

51,860.73 -306.69 (-0.59%)

7,464.20 -14.49 (-0.19%)

66,064.76 1,923.64 (3.00%)

10,542.79 -57.58 (-0.54%)

96.42 0.06 (0.07%)

110.27 -0.10 (-0.09%)

129.65 -0.46 (-0.35%)

0.59 0.00 (-0.05%)